NO990187L - Benzosulfon-derivater - Google Patents
Benzosulfon-derivaterInfo
- Publication number
- NO990187L NO990187L NO990187A NO990187A NO990187L NO 990187 L NO990187 L NO 990187L NO 990187 A NO990187 A NO 990187A NO 990187 A NO990187 A NO 990187A NO 990187 L NO990187 L NO 990187L
- Authority
- NO
- Norway
- Prior art keywords
- benzosulfon
- derivatives
- benzosulfon derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/73—Unsubstituted amino or imino radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/26—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C317/32—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
- C07C317/34—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having sulfone or sulfoxide groups and amino groups bound to carbon atoms of six-membered aromatic rings being part of the same non-condensed ring or of a condensed ring system containing that ring
- C07C317/36—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having sulfone or sulfoxide groups and amino groups bound to carbon atoms of six-membered aromatic rings being part of the same non-condensed ring or of a condensed ring system containing that ring with the nitrogen atoms of the amino groups bound to hydrogen atoms or to carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/70—Sulfur atoms
- C07D213/71—Sulfur atoms to which a second hetero atom is attached
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/84—Nitriles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/38—One sulfur atom
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Compositions Of Macromolecular Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP98100690 | 1998-01-16 |
Publications (3)
Publication Number | Publication Date |
---|---|
NO990187D0 NO990187D0 (no) | 1999-01-15 |
NO990187L true NO990187L (no) | 1999-07-19 |
NO312065B1 NO312065B1 (no) | 2002-03-11 |
Family
ID=8231273
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO19990187A NO312065B1 (no) | 1998-01-16 | 1999-01-15 | Benzosulfon-derivater, anvendelse og fremgangsmåte for fremstilling derav, samt medikament |
Country Status (34)
Country | Link |
---|---|
US (1) | US5990105A (no) |
EP (1) | EP0930302B1 (no) |
JP (1) | JP3249092B2 (no) |
KR (1) | KR100319250B1 (no) |
CN (1) | CN1148356C (no) |
AR (1) | AR014313A1 (no) |
AT (1) | ATE236136T1 (no) |
AU (1) | AU757841B2 (no) |
BR (1) | BR9900065A (no) |
CA (1) | CA2258454A1 (no) |
CO (1) | CO5090847A1 (no) |
CZ (1) | CZ12099A3 (no) |
DE (1) | DE69906397T2 (no) |
DK (1) | DK0930302T3 (no) |
ES (1) | ES2193607T3 (no) |
HK (1) | HK1022310A1 (no) |
HR (1) | HRP990011B1 (no) |
HU (1) | HUP9900120A3 (no) |
ID (1) | ID23234A (no) |
IL (1) | IL128027A (no) |
MA (1) | MA26599A1 (no) |
MY (1) | MY121778A (no) |
NO (1) | NO312065B1 (no) |
NZ (1) | NZ333706A (no) |
PE (1) | PE20000170A1 (no) |
PL (1) | PL194735B1 (no) |
PT (1) | PT930302E (no) |
RU (1) | RU2201922C2 (no) |
SG (1) | SG71898A1 (no) |
SI (1) | SI0930302T1 (no) |
TR (1) | TR199900090A2 (no) |
TW (1) | TW553938B (no) |
YU (1) | YU1199A (no) |
ZA (1) | ZA99254B (no) |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7030109B2 (en) | 1999-07-19 | 2006-04-18 | Pharmacia & Upjohn Company | 1,2,3,4,5,6-Hexahydroazepino[4,5-b]indoles containing arylsulfones at the 9-position |
MY122278A (en) | 1999-07-19 | 2006-04-29 | Upjohn Co | 1,2,3,4,5,6-hexahydroazepino[4,5-b]indoles containing arylsulfones at the 9-position |
DE19956791A1 (de) * | 1999-11-25 | 2001-05-31 | Merck Patent Gmbh | Neue Sulfonyloxazolamine |
US7034029B2 (en) | 2000-11-02 | 2006-04-25 | Wyeth | 1-aryl- or 1-alkylsulfonyl-heterocyclylbenzazoles as 5-hydroxytryptamine-6 ligands |
EP1343756A2 (en) * | 2000-11-02 | 2003-09-17 | Wyeth | 1-aryl- or 1-alkylsulfonyl-heterocyclylbenzazoles as 5-hydroxytryptamine-6 ligands |
HUP0401235A2 (hu) | 2001-08-10 | 2004-10-28 | F. Hoffmann-La Roche Ag | 5-HT6 receptor affinitással rendelkező arilszulfonil-származékok, eljárás előállításukra és a vegyületeket tartalmazó gyógyászati készítmények |
EP1434578A1 (en) * | 2001-10-09 | 2004-07-07 | PHARMACIA & UPJOHN COMPANY | Arylsulphonyl-substituted tetrahydro- and hexahydro-carbazoles as 5-ht-6 receptor ligands |
PL209872B1 (pl) * | 2002-03-27 | 2011-10-31 | Glaxo Group Ltd | Pochodna chinolinowa, sposób jej wytwarzania i jej zastosowanie oraz zawierająca ją farmaceutyczna kompozycja |
US6875771B2 (en) | 2002-07-26 | 2005-04-05 | Bristol-Myers Squibb Company | Pyridopyrimidine derivatives as 5-HT6 antagonists |
KR101052482B1 (ko) * | 2002-11-21 | 2011-07-28 | 노바티스 백신즈 앤드 다이아그노스틱스 인코포레이티드 | 포스포티딜이노시톨(pi) 3-키나제 억제제인 2,4,6-삼치환피리미딘 및 암의 치료에서 이들의 사용 |
GB0305575D0 (en) | 2003-03-11 | 2003-04-16 | Glaxo Group Ltd | Novel compounds |
GB0419192D0 (en) * | 2004-08-27 | 2004-09-29 | Merck Sharp & Dohme | Therapeutic agents |
SI1831159T1 (sl) * | 2004-12-21 | 2010-04-30 | Hoffmann La Roche | Derivati tetralina in indana ter njune uporabe |
JP2008540438A (ja) * | 2005-05-04 | 2008-11-20 | バーテックス ファーマシューティカルズ インコーポレイテッド | イオンチャネルのモジュレーターとして有用なピリジン |
JO2660B1 (en) | 2006-01-20 | 2012-06-17 | نوفارتيس ايه جي | Pi-3 inhibitors and methods of use |
EP2439201B1 (en) | 2006-06-16 | 2013-08-07 | H. Lundbeck A/S | Compounds with combined sert, 5-ht3 and 5-ht1a activity |
MX2009004947A (es) * | 2006-11-09 | 2009-05-19 | Hoffmann La Roche | Arilsulfonil-pirrolidinas como inhibidores 5-hidroxitriptaminas6 (5-ht6). |
EP2118087B1 (en) * | 2007-02-06 | 2012-03-28 | Novartis AG | Pi 3-kinase inhibitors and methods of their use |
CA2703157C (en) * | 2007-10-26 | 2013-02-05 | Suven Life Sciences Limited | Amino arylsulfonamide compounds and their use as 5-ht6 ligands |
WO2009128058A1 (en) | 2008-04-18 | 2009-10-22 | UNIVERSITY COLLEGE DUBLIN, NATIONAL UNIVERSITY OF IRELAND, DUBLIN et al | Psycho-pharmaceuticals |
UA100192C2 (en) | 2008-11-11 | 2012-11-26 | УАЙТ ЭлЭлСи | 1-(arylsulfonyl)-4-(piperazin-1-yl)-1h-benzimidazoles as 5-hydroxytryptamine-6 ligands |
RU2443697C1 (ru) | 2010-12-21 | 2012-02-27 | Александр Васильевич Иващенко | Замещенные метил-амины, антагонисты серотониновых 5-ht6 рецепторов, способы получения и применения |
MX342326B (es) | 2011-09-27 | 2016-09-26 | Novartis Ag | 3-pirimidin-4-il-oxazolidin-2-onas como inhibidoras de idh mutante. |
UY34632A (es) | 2012-02-24 | 2013-05-31 | Novartis Ag | Compuestos de oxazolidin- 2- ona y usos de los mismos |
US9296733B2 (en) | 2012-11-12 | 2016-03-29 | Novartis Ag | Oxazolidin-2-one-pyrimidine derivative and use thereof for the treatment of conditions, diseases and disorders dependent upon PI3 kinases |
TWI686193B (zh) | 2013-01-18 | 2020-03-01 | 美商卡爾迪奧克斯爾製藥公司 | 具有增進之治療指數的硝醯基予體 |
ES2665619T3 (es) | 2013-03-14 | 2018-04-26 | Novartis Ag | 3-Pirimidin-4-il-oxazolidin-2-onas como inhibidores de IDH mutante |
JP6454346B2 (ja) | 2013-12-20 | 2019-01-16 | サンシャイン・レイク・ファーマ・カンパニー・リミテッドSunshine Lake Pharma Co.,Ltd. | 芳香族複素環式化合物及び医薬におけるその応用 |
GB201514021D0 (en) | 2015-08-07 | 2015-09-23 | Arner Elias Set Jeno | Novel Pyridines and their use in the treatment of cancer |
JP2020507624A (ja) | 2017-02-07 | 2020-03-12 | オブリーク セラピューティクス アーベー | スルフィニルピリジンおよび癌の治療におけるそれらの使用 |
EP3580209A1 (en) | 2017-02-07 | 2019-12-18 | Oblique Therapeutics AB | Heterocyclylsulfonyl-substituted pyridines and their use in the treatment of cancer |
MX2019009351A (es) | 2017-02-07 | 2019-09-19 | Oblique Therapeutics Ab | Piridinas sustituidas con heteroarilsulfonilo y su uso en el tratamiento del cancer. |
EP3580203A1 (en) | 2017-02-07 | 2019-12-18 | Oblique Therapeutics AB | Hydrocarbylsulfonyl-substituted pyridines and their use in the treatment of cancer |
HUE057970T2 (hu) | 2018-03-08 | 2022-06-28 | Incyte Corp | Aminopirazindiol-vegyületek mint PI3K-Y inhibitorok |
US11046658B2 (en) | 2018-07-02 | 2021-06-29 | Incyte Corporation | Aminopyrazine derivatives as PI3K-γ inhibitors |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS55151560A (en) * | 1979-05-14 | 1980-11-26 | Ishihara Sangyo Kaisha Ltd | Pyridylthioaniline compound |
JPS60185764A (ja) * | 1984-03-05 | 1985-09-21 | Wako Pure Chem Ind Ltd | ピリジン誘導体の新規な製造法 |
EP0513262B1 (de) * | 1990-11-27 | 2000-04-05 | MERCK PATENT GmbH | 3,6-disubstituierte-2-fluoropyridine |
GB9214120D0 (en) * | 1991-07-25 | 1992-08-12 | Ici Plc | Therapeutic amides |
JPH06127956A (ja) * | 1992-10-16 | 1994-05-10 | Copal Co Ltd | ガラスレンズの成形装置 |
JP3907721B2 (ja) * | 1995-08-23 | 2007-04-18 | 株式会社クラレ | 2−アラルキルオキシピリジン類の製造法 |
JP3907722B2 (ja) * | 1995-08-23 | 2007-04-18 | 株式会社クラレ | 2−ヒドロキシピリジン類および/または2(1h)−ピリドン類の製造法 |
EP0894791A4 (en) * | 1996-03-29 | 2001-07-11 | Ube Industries | PYRIMIDINE COMPOUNDS, PROCESS FOR THE PRODUCTION THEREOF AND BACTERICIDES FOR AGRICULTURE AND HORTICULTURE |
JP3814885B2 (ja) * | 1996-09-03 | 2006-08-30 | 宇部興産株式会社 | 2−シアノピリミジン誘導体、その製造法及び農園芸用の殺菌剤 |
JP2002507197A (ja) * | 1997-05-30 | 2002-03-05 | ビーエーエスエフ アクチェンゲゼルシャフト | 置換チオピリジン |
KR100396431B1 (ko) * | 1998-01-26 | 2003-09-02 | 가부시키가이샤 구라레 | 2-술포닐피리딘 유도체 및 2-[((2-피리딜)메틸)티오]-1h-벤즈이 |
-
1999
- 1999-01-08 DK DK99100149T patent/DK0930302T3/da active
- 1999-01-08 EP EP99100149A patent/EP0930302B1/en not_active Expired - Lifetime
- 1999-01-08 AT AT99100149T patent/ATE236136T1/de not_active IP Right Cessation
- 1999-01-08 ES ES99100149T patent/ES2193607T3/es not_active Expired - Lifetime
- 1999-01-08 SI SI9930252T patent/SI0930302T1/xx unknown
- 1999-01-08 PT PT99100149T patent/PT930302E/pt unknown
- 1999-01-08 DE DE69906397T patent/DE69906397T2/de not_active Expired - Fee Related
- 1999-01-12 NZ NZ333706A patent/NZ333706A/xx unknown
- 1999-01-12 PE PE1999000027A patent/PE20000170A1/es not_active Application Discontinuation
- 1999-01-13 IL IL12802799A patent/IL128027A/en unknown
- 1999-01-13 YU YU1199A patent/YU1199A/sh unknown
- 1999-01-13 KR KR1019990000667A patent/KR100319250B1/ko not_active IP Right Cessation
- 1999-01-13 TW TW088100465A patent/TW553938B/zh not_active IP Right Cessation
- 1999-01-13 SG SG1999000077A patent/SG71898A1/en unknown
- 1999-01-13 CA CA002258454A patent/CA2258454A1/en not_active Abandoned
- 1999-01-13 HR HR98100690.1 patent/HRP990011B1/xx not_active IP Right Cessation
- 1999-01-14 CO CO99001735A patent/CO5090847A1/es unknown
- 1999-01-14 TR TR1999/00090A patent/TR199900090A2/xx unknown
- 1999-01-14 MY MYPI99000139A patent/MY121778A/en unknown
- 1999-01-14 ZA ZA9900254A patent/ZA99254B/xx unknown
- 1999-01-14 PL PL330841A patent/PL194735B1/pl not_active IP Right Cessation
- 1999-01-14 BR BR9900065-2A patent/BR9900065A/pt not_active Application Discontinuation
- 1999-01-14 CZ CZ99120A patent/CZ12099A3/cs unknown
- 1999-01-14 JP JP00741099A patent/JP3249092B2/ja not_active Expired - Fee Related
- 1999-01-15 NO NO19990187A patent/NO312065B1/no unknown
- 1999-01-15 AU AU12110/99A patent/AU757841B2/en not_active Ceased
- 1999-01-15 ID IDP990038D patent/ID23234A/id unknown
- 1999-01-15 US US09/232,775 patent/US5990105A/en not_active Expired - Fee Related
- 1999-01-15 CN CNB99100955XA patent/CN1148356C/zh not_active Expired - Fee Related
- 1999-01-15 AR ARP990100132A patent/AR014313A1/es unknown
- 1999-01-15 MA MA25434A patent/MA26599A1/fr unknown
- 1999-01-15 RU RU99101350/04A patent/RU2201922C2/ru not_active IP Right Cessation
- 1999-01-15 HU HU9900120A patent/HUP9900120A3/hu unknown
-
2000
- 2000-02-28 HK HK00101191A patent/HK1022310A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20010193L (no) | Tiobenzimidazol-derivater | |
ATE236136T1 (de) | Benzosulfonderivate | |
NO20010514L (no) | Aminometylkarboksylsyre-derivater | |
DK1005446T3 (da) | N-aroylphenylalaninderivater | |
ATE235220T1 (de) | Resorcinderivate | |
DE69940913D1 (de) | Ldautomat | |
ID22781A (id) | Turunan-turunan nikotinamida | |
ATE259810T1 (de) | Phenyl-xanthinderivate | |
DE69934788D1 (de) | Biozide benzylbiphenylderivative | |
DE69817186D1 (de) | Diaminorhodamin-derivate | |
DE69910986D1 (de) | Atmosphärenteilchenanalysator | |
PT928790E (pt) | Derivados de tiazolo | |
ATE440854T1 (de) | 5-deoxy-cytidin-derivate | |
PT1056716E (pt) | Derivados de ciclo-hexanodiolo | |
DK1115716T3 (da) | 2-phenylpyran-4-on-derivater | |
ATE233253T1 (de) | Chromanderivate | |
DK1134219T3 (da) | Cucloalkylsubstituerede aminomethylpyrrolidinderivater | |
DE69829682D1 (de) | Cis-disubstituierte aminocycloalkyl-pyrrolidin-derivate | |
DK1060183T3 (da) | 5-deoxycytidinderivater | |
DE69828780D1 (de) | Amidinocamptpthecin-derivate | |
DE59807217D1 (de) | Nadellager | |
NO981495D0 (no) | Phenoxymetylpiperidin-derivater | |
PT1123283E (pt) | Derivados de tiazole | |
DK0966437T3 (da) | 5-Aroylnaphthalenderivater | |
DK1015447T3 (da) | Piperidinylmethyloxazolidinonderivat |